Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has issued an update.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has completed the disposal of its remaining 12% equity interest in Tianjin TSKF Pharmaceutical Co., Ltd. to Haleon China Co., Ltd. and Haleon CH SARL. This transaction, valued at RMB1,623,466,666.67, marks the company’s exit from any equity interest in the Target Company, potentially impacting its operational focus and market positioning.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products.
Find detailed analytics on 2TZ stock on TipRanks’ Stock Analysis page.